Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) reports that the United States Food and Drug administration has granted ISIS-TTRRx fast track designation ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE